These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 1604324)
1. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Alarcón-Segovia D; Pérez-Vázquez ME; Villa AR; Drenkard C; Cabiedes J Semin Arthritis Rheum; 1992 Apr; 21(5):275-86. PubMed ID: 1604324 [TBL] [Abstract][Full Text] [Related]
2. Influence of disease duration, continued followup and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus. Pérez-Vázquez ME; Villa AR; Drenkard C; Cabiedes J; Alarcón-Segovia D J Rheumatol; 1993 Mar; 20(3):437-42. PubMed ID: 8478848 [TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus. İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535 [TBL] [Abstract][Full Text] [Related]
4. Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus. Sabet A; Sibbitt WL; Stidley CA; Danska J; Brooks WM Stroke; 1998 Nov; 29(11):2254-60. PubMed ID: 9804631 [TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid antibody syndrome in renal transplantation: occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus. Stone JH; Amend WJ; Criswell LA Am J Kidney Dis; 1999 Dec; 34(6):1040-7. PubMed ID: 10585313 [TBL] [Abstract][Full Text] [Related]
6. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome. Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279 [TBL] [Abstract][Full Text] [Related]
7. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. Cabiedes J; Cabral AR; Alarcón-Segovia D J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989 [TBL] [Abstract][Full Text] [Related]
8. [Cardiological aspects of the antiphospholipid syndrome. Part I. Valvular lesions in the primary and secondary antiphospholipid syndrome and systemic lupus erythematosus]. Reshetniak TM; Kotel'nikova GP; Fomicheva OA; Kliukvina NG; Karpov IuA; Alexandrova EN; Alekberova ZS; Sergakova LM; Nasonova VA; Nasonov EL Kardiologiia; 2002; 42(8):38-43. PubMed ID: 12494093 [TBL] [Abstract][Full Text] [Related]
10. Anti-oxidized low-density-lipoprotein (OxLDL) antibodies in systemic lupus erythematosus with and without antiphospholipid syndrome. Hayem G; Nicaise-Roland P; Palazzo E; de Bandt M; Tubach F; Weber M; Meyer O Lupus; 2001; 10(5):346-51. PubMed ID: 11403265 [TBL] [Abstract][Full Text] [Related]
11. [Systemic lupus erythematosus and antiphospholipid syndrome - diagnostic and therapeutic problems]. Zdrojewski Z Wiad Lek; 2018; 71(1 pt 1):40-46. PubMed ID: 29558350 [TBL] [Abstract][Full Text] [Related]
13. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
14. Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: Analysis of a cohort of 214 patients. Paule R; Morel N; Le Guern V; Fredi M; Coutte L; Belhocine M; Mouthon L; le Jeunne C; Chauvin A; Piette JC; Costedoat-Chalumeau N Autoimmun Rev; 2018 Sep; 17(9):866-872. PubMed ID: 30005859 [TBL] [Abstract][Full Text] [Related]
15. Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome). Cimaz R; Meroni PL; Shoenfeld Y Lupus; 2006; 15(4):191-7. PubMed ID: 16686257 [TBL] [Abstract][Full Text] [Related]
16. A qualitative investigation of the experiences of patients living with antiphospholipid antibodies. Cardwell FS; Kobza AO; Elliott SJ; Gibson PS; Soliman N; Skeith L; Clarke AE; Barber MR Lupus; 2024 Sep; 33(10):1043-1058. PubMed ID: 39045728 [TBL] [Abstract][Full Text] [Related]
18. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome. Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539 [TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of antiphospholipid antibody in pediatric patients and review of literature]. Xiao HJ; Yang JY; Gao TJ; Huang JP; Yao Y; Zhang Y Zhonghua Er Ke Za Zhi; 2004 Aug; 42(8):571-3. PubMed ID: 15347440 [TBL] [Abstract][Full Text] [Related]
20. Patients with systemic lupus erythematosus and antiphospholipid syndrome undergoing cardiac valve surgery. Arif R; Farag M; Seppelt P; Beller CJ; Ruhparwar A; Karck M; Kallenbach K J Heart Valve Dis; 2015 Mar; 24(2):228-35. PubMed ID: 26204691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]